Holter of Movement in Patients with Multiple Sclerosis in Controlled Environment.

Laurent Servais

Status: Completed

Conditions: Multiple Sclerosis

Treatments: Device: Actimyo°; Device: IMU

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT04888689

ActiSEP. Part 1.

Details and patient eligibility

About

ActiSEP is a multicentric academic study. Ambulant patients with multiple sclerosis may be included on a voluntary basis. We plan to include a group of approximately 20 patients with MS.

This study include a unique evaluation in the laboratory of analysis of human movement. A set of tasks will be performed by patients wearing of two magneto-inertial sensors.

Enrollment: 21 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Confirmed MS diagnosis,
• Over 18 years old,
• Ambulant patients,
• Signed informed consent,
• No clinical and / or radiological relapse within 3 months.

Exclusion criteria

• Patients with excessive cognitive disorders, limiting the understanding of task or with apparent communication difficulties hindering data collection.
• Any other previous or present pathology having an impact on motor function.
• Recent surgery or trauma (less than 6 months) in the upper or lower limbs

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

21 participants in 1 patient group

MS patients

Experimental group

Description:

Ambulant patients with multiple sclerosis

Treatment:

Device: IMU

Device: Actimyo°